The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline | Zendy

Ifigeneia Mavranezouli | Zendy

Open Access

The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline

Author(s) -

Ifigeneia Mavranezouli

Publication year - 2008

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/den091

Subject(s) - medicine , long acting reversible contraception , family planning , levonorgestrel , discontinuation , cost effectiveness , unintended pregnancy , contraceptive implant , gynecology , intrauterine device , pill , medroxyprogesterone acetate , developed country , cost effectiveness analysis , obstetrics , population , surgery , nursing , environmental health , research methodology , hormone , risk analysis (engineering)

Long-acting reversible contraceptive (LARC) methods are highly effective in preventing unintended pregnancies. However, their uptake is low in much of the developed world. This study aimed at assessing the cost-effectiveness of LARC methods from the British National Health Service (NHS) perspective.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research